J7519 - Injection, mycophenolate mofetil, 10 mg |
10 MG |
0.401 |
- |
- |
- |
- |
- |
- |
|
|
J7520 - Sirolimus, oral, 1 mg |
1 MG |
1.266 |
- |
- |
- |
- |
- |
- |
|
|
J7521 - Tacrolimus, granules, oral suspension, 0.1 mg |
0.1 MG |
1.282 |
- |
- |
- |
- |
- |
- |
|
|
J7525 - Tacrolimus, parenteral, 5 mg |
5 MG |
259.956 |
- |
- |
- |
- |
- |
- |
|
|
J7527 - Everolimus, oral, 0.25 mg |
0.25 MG |
1.244 |
- |
- |
- |
- |
- |
- |
|
|
J7528 - Mycophenolate mofetil, for suspension, oral, 100 mg |
100 MG |
0.311 |
- |
- |
- |
- |
- |
- |
|
|
J7601 - Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg |
3 MG |
52.117 |
- |
- |
- |
- |
- |
- |
|
|
J7605 - Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
15 mcg |
0.727 |
- |
- |
- |
- |
- |
- |
|
|
J7606 - Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
20 MCG |
1.783 |
- |
- |
- |
- |
- |
- |
|
|
J7608 - Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram |
1 GM |
8.541 |
- |
- |
- |
- |
- |
- |
|
|
J7611 - Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
1 MG |
0.237 |
- |
- |
- |
- |
- |
- |
|
|
J7612 - Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
0.5 MG |
0.319 |
- |
- |
- |
- |
- |
- |
|
|
J7613 - Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1 MG |
0.076 |
- |
- |
- |
- |
- |
- |
|
|
J7614 - Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
0.5 MG |
0.086 |
- |
- |
- |
- |
- |
- |
|
|
J7620 - Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
2.5 MG/0.5 MG |
0.207 |
- |
- |
- |
- |
- |
- |
|
|
J7626 - Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
0.5 MG |
1.095 |
- |
- |
- |
- |
- |
- |
|
|
J7631 - Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
10 MG |
0.814 |
- |
- |
- |
- |
- |
- |
|
|
J7639 - Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
1 MG |
55.172 |
- |
- |
- |
- |
- |
- |
|
|
J7644 - Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
1 MG |
0.443 |
- |
- |
- |
- |
- |
- |
|
|
J7677 - Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram |
1 MCG |
0.196 |
- |
- |
- |
- |
- |
- |
|
|
J7682 - Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams |
300 MG |
7.766 |
- |
- |
- |
- |
- |
- |
|
|
J7686 - Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg |
1.74 MG |
789.177 |
- |
- |
- |
- |
- |
- |
|
|
J8501 - Aprepitant, oral, 5 mg |
5 MG |
2.389 |
- |
- |
- |
- |
- |
- |
|
|
J8502 - Injection, aprepitant (aponvie), 1 mg |
1 MG |
1.953 |
- |
- |
- |
- |
- |
- |
|
|
J8515 - Cabergoline, oral, 0.25 mg |
0.25 MG |
0.154 |
- |
- |
- |
- |
- |
- |
|
|